You are invited to a Treatment-Resistant Schizophrenia Promotional Webinar
Viatris is delighted to invite you to our upcoming TRS webinar featuring Professor Ramalingam Chithiramohan, Consultant Psychiatrist, Birmingham and Solihull Mental Health Foundation Trust. The presentation will focus on a treatment-resistant schizophrenia masterclass.
A speaker Q&A session will follow the presentation and a “Certificate of Attendance” will be available after the webinar.
Speaker

Professor Ramalingam Chithiramohan
Consultant Psychiatrist, Birmingham and Solihull NHS Foundation Trust
Agenda
Webinar platform opens for registered delegates
12.35
Welcome and introduction
Umran Mohammed, Therapy Development Manager, Viatris Mental Health UK
13.30
Treatment-resistant schizophrenia: a masterclass for healthcare professionals
Professor Ramalingam Chithiramohan
13.45
Q&A Session
Professor Ramalingam Chithiramohan
Webinar closes
Clozaril®/Clozapine Mylan is indicated in treatment-resistant schizophrenic patients and in schizophrenia patients who have severe, untreatable neurological adverse reactions to other antipsychotic agents, including atypical antipsychotics. Treatment resistance is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two different antipsychotic agents, including an atypical antipsychotic agent, prescribed for adequate duration.